Company Profile



San Francisco, California, USA

Founded Year




Operating Status


Social Media


Abraham Heifets
Co-Founder, CEO

Izhar Wallach
Co-Founder, CTO


Atomwise is a cutting-edge technology company that harnesses the power of artificial intelligence to revolutionize the field of drug discovery.

Using its proprietary AI engine, AtomNet, the company is able to rapidly and accurately screen millions of potential drug compounds, vastly accelerating the drug development process and bringing life-saving therapies to market more quickly.

Atomwise's AtomNet technology is truly groundbreaking. It uses deep learning algorithms to simulate how potential drug compounds will interact with target proteins in the body, predicting their effectiveness and potential side effects with incredible accuracy.

This allows Atomwise to rapidly identify promising drug candidates and dramatically reduce the time and cost of bringing new therapies to market.

With a team of world-class scientists, engineers, and business leaders, Atomwise is rapidly becoming a leader in the field of AI-driven drug discovery.

Its cutting-edge technology has already attracted the attention of major pharmaceutical companies and investors, and the company is poised to make a major impact on the future of medicine.


In the race for drug discovery, AI is the new superpower.

Utilizing advanced technology, Atomwise is a pharmaceutical company at the forefront of small molecule drug discovery, utilizing the power of AI to create a paradigm shift in the industry.

The Atomwise team has pioneered the use of deep learning for structure-based drug design, which forms the basis of its top-of-the-line AI discovery engine. What sets Atomwise apart is its capacity to discover and optimize novel chemical matter.

Atomwise's discovery engine has been extensively validated and has achieved success in over 185 projects to-date, with a diverse range of protein types and numerous "hard-to-drug" targets.

With a focus on creating a wholly-owned pipeline of small-molecule drug candidates, Atomwise currently has three programs in lead optimization and over 30 programs in discovery.

Similar Companies

About Us

futureTEKnow is a global database of emerging technology companies. Discover the latest disruptors and innovators in the field.



Trending Today